Description
Scripps 6th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2023
The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments.
- Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.
Educational Objectives
After attending this live activity, participants should be able to:
- Evaluate current and emerging treatment options for cardiac amyloidosis.
- Discuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.
- Assess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.
- Analyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.
- Employ management strategies for venous thromboembolism and other cardiovascular complications that may occur in patients with cancer.
- Demonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.
Target Audience
- Cardiologists
- Oncologists
- Internists
- RN, NP, PA
- Sonographers
+ Topics:
- brochure_cmp23.pdf
- SESSION I CARDIOMYOPATHIES AL Amyloidosis Making the Diagnosis.mp4
- SESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Making the Diagnosis.mp4
- SESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Therapeutic Principles.mp4
- SESSION I CARDIOMYOPATHIES Current and Emerging Treatments for AL Amyloidosis.mp4
- SESSION I CARDIOMYOPATHIES Current Treatments for ATTR.mp4
- SESSION I CARDIOMYOPATHIES Emerging Therapies for ATTR.mp4
- SESSION I CARDIOMYOPATHIES Genetic Cardiomyopathies Who to Screen and What to Look For.mp4
- SESSION I CARDIOMYOPATHIES How To Make the Diagnosis of ATTR.mp4
- SESSION I CARDIOMYOPATHIES Hypertrophic Cardiomyopathy Diagnosis and Treatment.mp4
- SESSION I CARDIOMYOPATHIES Panel Discussion Q&A.mp4
- SESSION I CARDIOMYOPATHIES Transthyretin Amyloidosis (ATTR) Who to Suspect.mp4
- SESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Cardiologist’s Perspective.mp4
- SESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Oncologist’s Perspective.mp4
- SESSION II CARDIO-ONCOLOGY Cardiac Disease Monitoring in Cancer Survivors.mp4
- SESSION II CARDIO-ONCOLOGY Incorporating Multi-Modality Imaging in Cardio-Oncology.mp4
- SESSION II CARDIO-ONCOLOGY Management of End-Stage Heart Failure in the Cancer Survivor.mp4
- SESSION II CARDIO-ONCOLOGY Management of VTE in the Cancer Patient.mp4
- SESSION II CARDIO-ONCOLOGY Panel Discussion Q&A.mp4
- SESSION II CARDIO-ONCOLOGY Strategies to Minimize Radiation-Induced Heart Disease.mp4
